Influenza drug prevents SARS-CoV-2 from invading host cells
German and British scientists have discovered that the protease inhibitor aprotinin can prevent the SARS CoV-2 virus from entering host cells.
SARS-CoV-2 virus
Nasal spray with nanoparticles as protection against corona
Universities of Uppsala and Mainz are working separately on a drug against the covid-19 virus. The Swedish medicine is aimed at slowing down the virus, the German medicine is focused on prevention.
Corona pandemic as a ‘lesson’ for solving the climate crisis?
German researchers have analyzed what lessons we can learn from dealing with the corona pandemic that might help us get a grip on the climate crisis.
Scientists are confident that SARS-CoV-2 vaccines will be available as early as the end of 2020
The German Paul Ehrlich Institute (PEI) is confident that a vaccine against the novel SARS CoV-2 coronavirus could be available by the end of 2020.
This is how SARS-CoV-2 shuts down our immune system
Researchers from Munich and Ulm have shown how the novel coronavirus suppresses the immune response by disabling protein expression in the ribosomes.
Follow-up: UV-C radiation – ‘powerful tool’ in the fight against coronavirus
In the weekly ‘follow-up’ section we present a sequel to last week’s best-read article here on Innovation Origins. This week it was the story about […]
Higher temperatures prolong the lifespan of the SARS-CoV-2 virus
Conventional viruses spread most effectively at colder temperatures. Like the flu virus. This strikes every year in winter and costs the lives of as many […]